Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis
National Cancer Institute (U01 CA230694, R01 CA222900, R01 CA212008, and U24ca086368) and Cancer Prevention Research Institute of Texas (CPRIT) (RP200554).
Authors
- Kinpritma Sangha (ORCID: https://orcid.org/0000-0002-3302-3351)
- Yujin Hoshida (ORCID: https://orcid.org/0000-0001-9430-1426)
- Amit G. Singal (ORCID: https://orcid.org/0000-0002-1172-3971)
- Naoto Fujiwara (ORCID: https://orcid.org/0000-0002-4109-3421)
- Szu‐Yu Zoe Kao (ORCID: https://orcid.org/0000-0002-4987-3983)
- Neehar D. Parikh (ORCID: https://orcid.org/0000-0002-5874-9933)
Institutions
- University of Michigan (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1016/j.eclinm.2024.102755
- Citations
- 25
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 9.24
Funders
- Cancer Prevention and Research Institute of Texas
- European Commission
- National Institutes of Health
- National Cancer Institute